Back to

Martin Møller

Senior Partner, Copenhagen
Helps pharmaceutical and biotech clients identify strategic and operational opportunities for growth and innovation and supports them through transformation and change

About Martin

Martin Møller works with strategy, transformation and innovation in pharmaceuticals and medical products companies and other industries where innovation plays a central role.

Recent project highlights include the creation of global launch plans that addressed supply, regulatory, and commercial issues for a primary-care blockbuster; support to a global R&D strategy and transformation program for a major pharma company; identification of strategic and operational opportunities in a small-molecule-focused R&D organization; development of a research strategy to help a client enter selected new disease areas; and the design of a new approach to cross-functional management of R&D projects.

Published work

Fast-forward: Will the speed of COVID-19 vaccine development reset industry norms?,” McKinsey & Company, May 2021

Unlocking the power of translational medicine,” McKinsey & Company, February 2020

Big, bigger, biggest data: CTO Peter Løngreen on Denmark’s national genome project,” McKinsey & Company, February 2020

The fragmentation of biopharmaceutical innovation,” Nature Reviews Drug Discovery, March 2019

Trends in clinical success rates,” Nature Reviews Drug Discovery, May 2016

Improving R&D productivity,” Nature Reviews Drug Discovery, June 2015

Outlook for the next 5 years in drug innovation,” Nature Reviews Drug Discovery, June 2012

Escaping the sword of Damocles: Toward a new future for pharmaceutical R&D,” (PDF–1.76 MB), McKinsey, 2012


University of Copenhagen
MA in comparative literature